Combination of cytoplasmic and nuclear girdin expression is an independent prognosis factor of breast cancer.

作者: Huikun Zhang , Feng Yu , Fengxia Qin , Ying Shao , Wei Chong

DOI: 10.1096/FJ.201700825RR

关键词: Breast cancerPrognostic factorMetastasisBiologyChromatinCytoplasmHuman breastNuclear localization sequenceCancer researchSubcellular distribution

摘要: Girdin is an actin-binding protein playing key roles in the development of various carcinomas. Although online tools have predicted nuclear localization girdin with a high probability, convincing proof has rarely been provided until now. The purpose this study was to discover girdin's precise subcellular distribution and potential prognostic value corresponding its localization. detected human breast cancer cell line >800 samples tissue by clinical pathologic analysis. In study, we discovered for first time that could attach chromatin interact topoisomerase-IIα nucleus. Cytoplasmic exhibited different prognosis cancer: cytoplasmic expression independent factor progression-free survival (PFS), whereas overall (OS). More important, combination both OS PFS. conclusion, our research results strongly recommend analysis prediction cancer.-Zhang, H., Yu, F., Qin, Shao, Y., Chong, W., Guo, Z., Liu, X., Fu, L., Gu, Ma, Y. Combination cancer.

参考文章(45)
I. Lopez-Sanchez, M. Garcia-Marcos, Y. Mittal, N. Aznar, M. G. Farquhar, P. Ghosh, Protein kinase C-theta (PKCθ) phosphorylates and inhibits the guanine exchange factor, GIV/Girdin Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 5510- 5515 ,(2013) , 10.1073/PNAS.1303392110
Caigang Liu, Yanjun Zhang, Hong Xu, Ruishan Zhang, Hua Li, Ping Lu, Feng Jin, Girdin protein: a new potential distant metastasis predictor of breast cancer. Medical Oncology. ,vol. 29, pp. 1554- 1560 ,(2012) , 10.1007/S12032-011-0087-6
KE CAO, WENTING JIANG, PEIGUO CAO, QIONG ZOU, SHENG XIAO, JIANDA ZHOU, CHENGHUI HUANG, Talen-mediated girdin knockout downregulates cell proliferation, migration and invasion in human esophageal carcinoma ECA109 cells Molecular Medicine Reports. ,vol. 10, pp. 848- 854 ,(2014) , 10.3892/MMR.2014.2268
CAIHUA WANG, JIE LIN, LURONG LI, YUN WANG, Expression and clinical significance of girdin in gastric cancer Molecular and Clinical Oncology. ,vol. 2, pp. 425- 428 ,(2014) , 10.3892/MCO.2014.265
TAKAHIRO SHIBATA, YOICHI MATSUO, TOMOYA SHAMOTO, TAKAHISA HIROKAWA, KEN TSUBOI, HIROKI TAKAHASHI, HIDEYUKI ISHIGURO, MASAHIRO KIMURA, HIROMITSU TAKEYAMA, HIROSHI INAGAKI, Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma. Oncology Reports. ,vol. 29, pp. 2127- 2132 ,(2013) , 10.3892/OR.2013.2406
L Tomiyama, T Sezaki, M Matsuo, K Ueda, N Kioka, Loss of Dlg5 expression promotes the migration and invasion of prostate cancer cells via Girdin phosphorylation. Oncogene. ,vol. 34, pp. 1141- 1149 ,(2015) , 10.1038/ONC.2014.31
Atsushi Enomoto, Hideki Murakami, Naoya Asai, Nobuhiro Morone, Takashi Watanabe, Kumi Kawai, Yoshiki Murakumo, Jiro Usukura, Kozo Kaibuchi, Masahide Takahashi, Akt/PKB Regulates Actin Organization and Cell Motility via Girdin/APE Developmental Cell. ,vol. 9, pp. 389- 402 ,(2005) , 10.1016/J.DEVCEL.2005.08.001
Mahmoud R. Khoshnoud, Tommy Fornander, Hemming Johansson, Lars-Erik Rutqvist, Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen. Breast Cancer Research and Treatment. ,vol. 107, pp. 71- 78 ,(2007) , 10.1007/S10549-007-9520-0
Mikel Garcia-Marcos, Pradipta Ghosh, Marilyn G. Farquhar, GIV/Girdin Transmits Signals from Multiple Receptors by Triggering Trimeric G Protein Activation Journal of Biological Chemistry. ,vol. 290, pp. 6697- 6704 ,(2015) , 10.1074/JBC.R114.613414
Mikel Garcia-Marcos, Pradipta Ghosh, Jason Ear, Marilyn G. Farquhar, A Structural Determinant That Renders Gαi Sensitive to Activation by GIV/Girdin Is Required to Promote Cell Migration Journal of Biological Chemistry. ,vol. 285, pp. 12765- 12777 ,(2010) , 10.1074/JBC.M109.045161